2003
Research Vice President Magid Abou-Gharbia, Ph.D. receives the prestigious Proctor Medal Award for his impact on drug discovery research in several therapeutic areas.

2003
Wyeth oncology researchers Drs. George Ellestead, Philip Hamann, and Janis Upeslacis receive the Discoverers Award from PhRMA for their work on gemtuzumab ozogamicin for Injection, the company’s first antibody targeted chemotherapy.

2003
A large-scale study finds significant reduction in invasive pheumococcal disease (IPD) in children vaccinated with Pneumococcal 7-Valent Conjugate Vaccine, the first and only vaccine approved for this disease in infants and toddlers.

2005
Wyeth vaccine scientists Drs, Ron Eby, Velupillai Puvanesarajah and Dace Madore are awarded the prestigious Discoverers Award from PhRMA for the development of Pneumococcal 7-Valent Conjugate Vaccine, the first conjugate vaccine to help prevent invasive Pneumococcal disease in infants and children.

2007
R&D Directions names Wyeth as having one of the “Top 10 Pipelines” and the “ Best Central Nervous System (CNS) Pipeline” in the pharmaceutical industry

2007
Wyeth scientists recognized by White House with prestigious National Madal of Technology    for Pneumococcal 7-Valent Conjugate Vaccine.